# Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

> **NCT03321968** · PHASE3 · COMPLETED · sponsor: **Medicago** · enrollment: 1202 (actual)

## Conditions studied

- Virus Diseases
- RNA Virus Infections
- Respiratory Tract Infections
- Respiratory Tract Disease
- Influenza

## Interventions

- **BIOLOGICAL:** Quadrivalent VLP Influenza Vaccine

## Key facts

- **NCT ID:** NCT03321968
- **Lead sponsor:** Medicago
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-29
- **Primary completion:** 2017-12-01
- **Final completion:** 2017-12-01
- **Target enrollment:** 1202 (ACTUAL)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321968, "Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03321968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*